Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Amgen Czech Republic generated the highest EBIIDA Margin in 2017 followed by Roche Czech Republic and Pfizer Czech Republic.
Amgen Czech Republic made EBITDA of CZK 49.0 mil, which translates into EBITDA margin of 11.8%. Historically, the firm’s margin reached an all time high of 13.8% in 2011 and an all time low of 6.20% in 2016. The average EBITDA margin in the last five years amounted to 8.59%.
Comparing Amgen Czech Republic with its closest peers, Roche Czech Republic generated EBITDA of CZK 475 mil with a EBITDA margin of 9.57% in 2017, Pfizer Czech Republic grossed CZK 156 mil (EBITDA margin of 4.36%) and Merck Czech Republic announced a profit of CZK 72.8 mil translating into a margin of 4.00%.
You can see all the companies ebitda margin data on the EBITDA Margin indicator page or you can download a special statistical dossier on the Czech Pharmaceutical Companies in the reports section.
Helgi Library 
